in patients who are taking T4 is not as great as in those patients who are not on T4 replacement.
The minimum daily human requirement for chromium necessary to maintain health is not known. Mertz (5) suggested an allowance of 50 to 200 pg/day. Schroeder et al. (6) found a mean chromium content of 72 pg in the daily diet of institutionalized subjects, and Levine et al. (7) reported a daily intake of 5 to 125 pg in the diet of elderly subjects. The requirement for chromium in the diet therefore seems to be variable, and may depend on the chemical form in which it is available. Impaired glucose tolerance in humans was improved by the simple addition of 150 ,ugof inorganic chromium salt to the daily diet (7-9), and various workers (10, 11) have reported the apparently beneficial effects of an organic form of chromium, "glucose tolerance factor" (GTF).
The improvements in glucose tolerance observed on supplementing the diet with chromium salt may have resulted from the conversion ofinorganic chromium to the biologically active form (GTF), which potentiates the effects of available insulin (12) . Now that more-reliable techniques for determination of chromium concentrations in plasma and urine have become available, findings reported for diabetic patients (13-15) and for healthy and diabetic subjects after an oral glucose distilled water. We sampled blood from them at 15, 30, 45, load (16, 17) All analyses for chromium in plasma and urine were done We used the following study protocol: The participants ate within 48 h of collection, by electrothermal atomic absorpno principal meal later than 2000 hours, light snacks only tion spectroscopy as described previously (18). from 2000 to 2200 hours, and water only after 2200 hours.
We measured urinary creatiine by a Jaffe-based reacThey supplied a midstream urine sample on rising the next tion, in an RA 1000 analyzer (Technicon method no. SM4-day, and urine and fasting blood samples at 0900 hours, for 0141K82). Urinary chromium was expressed relative to determinations of chromium and glucose, after which they creatimne to account for variations in urine volumes. drank 75 g of glucose dissolved in 250 mL of de-ionizedl
The significance of maximum changes in concentration was assessed by use ofStudent's unpaired t-test.
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Fg. (a)
The mean (± SEM) concentrations of the chromium and Figure 1(a and b) . In plasma the concentration of glucose was significantly (P <0.01) increased above basal concentration 15 min after the load; chromium was decreased below its basal value within 15 mm, reaching its lowest value (P <0.01) by 30 mm after the load. The glucose concentration was greatest slightly before the nadir of the chromium values, but this difference was not significant.
Several workers (17, 19) have reported a decrease in the concentration of chromium in plasma after a glucose load. Davidson and Burt (17) reported a decrease in plasma chromium concentrations in normal nonpregnant women, in response to both oral and intravenous glucose. Liu and Morris (19) found that serum chromium decreased in normal subjects after 1 h during a 3-h glucose-tolerance test. Glinsmann et al. (16) reported an increase in serum chromimm in response to a glucose challenge, and Levine et al. (7) reported similar increases in elderly subjects after glucose loading. Behne and Diehl (20) showed an increase in chromium in blood, which was greatest 60 to 120 mm after a 40 to 80 imol per mole of creatinine, which is 100-200 times greater than the values we observed. Alternatively, if the concentration of chromium in total extracellular water, whose volume is approximately 20 L (23), reflects that in plasma, then we would expect the urinary excretion of chromium to be at least 1000 times greater than the values we observed. We conclude that increased urinary loss is not responsible for the observed decrease in the concentration of plasma chromium.
Further studies will be needed to identify the principal mechanism responsible for the decrease in chromium concentration in plasma and to identify any abnormalities in dynamic responses in diabetic subjects, in whom the basal concentration of chromium in plasma is known to be significantly decreased (15).
